Why the study?
Does amiloride-hydrochlorothiazide compared to hydrochlorothiazide alone (with or without timolol) improve metabolic side effects while maintaining antihypertensive efficacy in patients with essential hypertension?
Does amiloride-hydrochlorothiazide compared to hydrochlorothiazide alone (with or without timolol) improve metabolic side effects while maintaining antihypertensive efficacy in patients with essential hypertension?
Amiloride-hydrochlorothiazide combined with timolol provides equivalent antihypertensive efficacy to hydrochlorothiazide with timolol while preventing hypokalemia.
Answers are grounded in this paper and cite their sources.
Supports amiloride-hydrochlorothiazide with timolol to avert hypokalemia at equivalent efficacy; extends RCT evidence for potassium-sparing combinations in hypertension.
The antihypertensive and metabolic effects of hydrochlorothiazide and amiloride—hydrochlorothiazide combination, alone and in combination with timolol, were studied in 26 patients with mild to moderately severe uncomplicated essential hypertension. All drugs were given in single daily doses as follows: hydrochlorothiazide 50 mg/day, amiloride—hydrochlorothiazide 5/50 mg/day (5 mg amiloride and 50 mg hydrochlorothiazide), timolol 20 mg/day. After six weeks of placebo treatment, the 26 patients were equally randomized into a double—blind HCTZ and HCTZ‐amiloride treatment period (weeks 7–18). Timolol was added to both groups of patients if the supine diastolic pressure at week 10 was higher than 90 mm Hg. Drug washout effects were observed for two weeks (weeks 19–20). Hydrochlorothiazide and amiloride—hydrochlorothiazide significantly lowered systolic and diastolic arterial pressure with the patient in the supine and upright position; the addition of timolol reduced the pressure further, and its effect was smooth and sustained. The heart rate was not affected by hydrochlorothiazide and amiloride—hydrochlorothiazide but was significantly decreased with the addition of timolol. The most common clinical and metabolic side effects observed, although not serious, were bradycardia from timolol and hypokalemia from hydrochlorothiazde. No hyperkalemia was noted with the combination of amiloride—hydrochlorothiazide and timolol. The results of the present study indicate that (1) the combination of timolol with either hydrochlorothiazide or amiloride—hydrochlorothiazide has equivalent antihypertensive actions; (2) the drugs can be effectively given in single daily doses; and (3) the combination of timolol with amiloride—hydrochlorothiazide has the additional advantage of preventing hypokalemia.
No takes yet. Share an insight, caveat, or question.
Chrysant et al. (1983) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: